Quality Means Business (QMB Inc.) Raises $2M Seed to Launch QualiVerse®
The Boston Foundation’s Business Equity Investment Fund and CEI Ventures Back Category-Defining AI Platform Transforming MedTech Quality, Regulatory, and Product Development
Quality Means Business (QMB), an rising chief in AI-driven MedTech SaaS, has closed a $2 million seed spherical to launch QualiVerse®, a Regulatory Intelligence Engine that helps medical machine innovators obtain compliance, speed up new product growth, and scale safely to market. The spherical, led by The Boston Foundation’s Business Equity Investment Fund and CEI Ventures, positions QMB as a category-defining firm on the intersection of AI, regulatory intelligence, and MedTech innovation.
“QMB is constructing the class infrastructure that MedTech has been lacking. Michel’s imaginative and prescient is deeply knowledgeable by lived expertise as each a regulator and SaaS product architect — and that is precisely the type of entrepreneur we again to redefine industries.” — Anthony Rust, Fund Manager of the Business Equity Investment Fund
“We’re excited to assist QMB in bringing vital innovation to the MedTech sector. QualiVerse® represents the kind of transformative know-how that not solely drives enterprise progress but in addition has the potential to enhance affected person outcomes on a worldwide scale. This aligns completely with our mission to spend money on corporations that create significant financial alternative whereas advancing social impression.” — Orlando Watkins, Vice President and Chief Program Officer of The Boston Foundation
“CEI Ventures is proud to accomplice with QMB. We’re particularly proud that every one present and deliberate jobs at QMB exceed the MIT Living Wage for Norfolk County, aligning with CEI Ventures’ Good Jobs Framework and our dedication to equitable, high-quality employment. QualiVerse® is the uncommon platform that marries technical sophistication with impression at scale — accelerating safer units to sufferers worldwide.” — Shannon Bean, Principal, CEI Ventures
“Quality and regulatory are the unsung heroes of medical innovation — they safeguard lives whereas too typically working within the shadows. With QualiVerse®, we’re giving these groups the clever platform they deserve — a system that makes compliance not a bottleneck, however a catalyst for innovation. As each a MedTech regulatory veteran and product chief in enterprise SaaS, I do know firsthand the price of delay and the urgency of getting this proper.” — Michel Moravia, Chairman & CEO of QMB
Building on early enterprise traction and pilot curiosity from main machine innovators, QMB will use the funding to develop engineering, deepen knowledge integrations, and advance RegTech-as-Infrastructure
pilots with MedTech producers in late 2025.
Strategic Governance
- Michel Moravia, Chairman & CEO – 15+ years in MedTech regulatory and high quality
- Orlando Watkins, Board Director – The Boston Foundation
- Robert Bennett, Board Director – Scaled EngageSmart® to PE acquisition
- Shannon Bean, Board Observer – CEI Ventures
The submit Quality Means Business (QMB Inc.) Raises $2M Seed to Launch QualiVerse® first appeared on AI-Tech Park.
